-
Mashup Score: 1EMN recommendations for COVID-19 vaccination in patients with MM - 2 year(s) ago
Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of disease characteristics and comorbidities, or treatment-mediated immune suppression. With regard to the COVID-19 pandemic, this can translate to prolonged infection and an increased risk of mortality following infection with SARS-CoV-2.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0How do CAR T-cell recipients respond to COVID-19 vaccination? - 2 year(s) ago
During the 4th European CAR T-Cell Meeting, the Multiple Myeloma Hub was pleased to speak to Arnon Nagler, Sheba Medical Center, Tel Aviv, IL. We asked, how do CAR T-cell recipients respond to COVID-19 vaccination?
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📹 #CART22 | The Multiple #Myeloma Hub was pleased to speak to @nagler_EBMT, Sheba Medical Center, Tel Aviv, IL. We asked, how do CAR T-cell recipients respond to #COVID-19 vaccination ❓ #mmsm #SESCOVID #SESCOVID19 https://t.co/yxw6LPh9HX
-
-
Mashup Score: 0COVID-19 | Multiple Myeloma Hub - 2 year(s) ago
Online resource for healthcare professionals, providing information, news & support relating to multiple myeloma
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
More on #COVID19 👉 https://t.co/u7Pd9SBnKk 👈 #COVIDvaccine #SESCOVID #mmsm #myeloma
-
-
Mashup Score: 1
Since the first cases of coronavirus disease 2019 (COVID-19) were reported in December 2019, more than 3 million people have died of the disease worldwide. Disease severity varies widely, with certain factors (including age and certain comorbidities) conferring a worse prognosis.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
💉What risk factors confer a worse prognosis for patients with #CLL who have SARS-CoV-2 infection, and how effective are the mRNA vaccines in this patient population? 🦠 Click here to read 👉 https://t.co/9HzmqEP1Z6 👈 #leusm #lymsm #leukemia #SESCOVID
-
-
Mashup Score: 0EMN recommendations for COVID-19 vaccination in patients with MM - 2 year(s) ago
Multiple myeloma (MM) and other monoclonal gammopathies can increase patient susceptibility to infection, either as a direct result of disease characteristics and comorbidities, or treatment-mediated immune suppression. With regard to the COVID-19 pandemic, this can translate to prolonged infection and an increased risk of mortality following infection with SARS-CoV-2.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
❗ European Myeloma Network recommendations for #COVID19 vaccination in patients with multiple #myeloma ❗ 📚 Read a summary of the consensus guidelines on the Multiple Myeloma Hub. 👉 https://t.co/p15g48fzgN 👈 #mmsm #COVIDvaccine #SESCOVID #SESCOVID19 https://t.co/LN4oRfyxVa
-
-
Mashup Score: 1COVID-19 lessons learnt in patients with multiple myeloma - 2 year(s) ago
During the 18th International Myeloma Workshop, Evangelos Terpos provided a summary of what has been learnt with respect to patients with multiple myeloma (MM) and COVID-19 so far.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
👀 What do we know so far about patients with #myeloma and #COVID19? 📚 Read on to find out how infection affects patients and their response to vaccination 👇 #mmsm #SESCOVID #SESCOVID19 https://t.co/SjaRH7JK4J
-
-
Mashup Score: 2EPICOVIDEHA registry: Epidemiology and outcomes in patients with hematologic malignancies infected with COVID-19 - 3 year(s) ago
Patients with hematologic malignancies (HMs) may have intensified immune dysregulation resulting from both therapeutic agents and malignancy burden. As a result, these patients are at increased risk for COVID-19 infection complications and mortality.
Source: multiplemyelomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📚 Read a summary of the EPICOVIDEHA registry results, outlining outcomes for patients with hematologic malignancies who have had #COVID19 infection 👇 #mmsm #COVID19 #SESCOVID #SARSCov2 https://t.co/Y8gnKL14Is
-
-
Mashup Score: 0EPICOVIDEHA registry: Epidemiology and outcomes in patients with hematologic malignancies infected with COVID-19 - 3 year(s) ago
Patients with hematologic malignancies (HMs) may have intensified immune dysregulation resulting from both therapeutic agents and malignancy burden. As a result, these patients are at increased risk for COVID-19 infection complications and mortality.
Source: lymphomahub.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🦠 Read a summary of the EPICOVIDEHA registry results, outlining outcomes for patients with hematologic malignancies who have had #COVID19 infection 👉 https://t.co/teKBVRy404 👈 #lymsm #COVID19 #SESCOVID #SARSCov2
-
👀 Catch up on this 👀 ❗ European Myeloma Network recommendations for #COVID19 vaccination in patients with multiple #myeloma ❗ 📚 Read a summary of the consensus guidelines on the Multiple Myeloma Hub. 👉 https://t.co/p15g48fzgN 👈 #mmsm #COVIDvaccine #SESCOVID #SESCOVID19 https://t.co/MfO2p6xOiY